Join the 200th Anniversary Celebration

Browse Pulmonary Fibrosis

Showing 1 to 20 of 155 Articles

Sort By:

  • Original Article

    Idiopathic pulmonary fibrosis is a chronic, progressive lung disease of unknown cause characterized by the histopathological pattern of usual interstitial pneumonia. The median survival of patients with idiopathic pulmonary fibrosis after diagnosis is 2 to 5 years. The use of glucocorticoids or…

    • May 24, 2012
    • The Idiopathic Pulmonary Fibrosis Clinical Research Network
    • N Engl J Med 2012; 366:1968-1977

      Many treatments used for idiopathic pulmonary fibrosis (IPF) have not been rigorously tested. This article reports discontinuation of treatment with prednisone, azathioprine, and N-acetylcysteine (NAC) because of increased mortality, as compared with N-acetylcysteine alone or placebo.

    • Correspondence

      To the Editor: Telomeres protect the ends of chromosomes from erosion; telomerase ensures their integrity. We report a case of familial idiopathic pulmonary fibrosis and bone marrow failure associated with a mutation in telomerase reverse transcriptase (TERT). The patient was a 56-year-old lifelong…

      • April 19, 2012
      • N Engl J Med 2012; 366:1551-1553
      • Free Full Text

      The authors report on a family with a new mutation in telomerase associated with pulmonary fibrosis and bone marrow failure. What fraction of patients with idiopathic pulmonary fibrosis have telomerase defects has not been defined, but the association should be kept in mind.

    • Original Article

      Idiopathic pulmonary fibrosis is a debilitating disease characterized by destruction of the gas-exchanging regions of the lung. Its pathogenesis is thought to involve aberrant wound healing mediated by multiple signaling pathways, resulting in progressive lung injury and scarring. Symptoms,…

      • September 22, 2011
      • Richeldi L., Costabel U., Selman M., et al.
      • N Engl J Med 2011; 365:1079-1087
      • Free Full Text

      Idiopathic pulmonary fibrosis is characterized by rapid loss of vital capacity, disability, and death. There are no effective treatments. Although this study failed to meets its primary end point, the data show therapeutic efficacy at a cost of substantial GI toxicity.

    • Editorial

      Fibrosis, or scarring, of the lung is a common consequence of certain types of pneumonias, and in such cases it is a localized and self-limited process. However, in conditions such as the complex group of disorders termed the idiopathic interstitial pneumonias, pulmonary fibrosis may be a…

      • September 22, 2011
      • Downey G.P.
      • N Engl J Med 2011; 365:1140-1141
      • Free Full Text

      Fibrosis, or scarring, of the lung is a common consequence of certain types of pneumonias, and in such cases it is a localized and self-limited process. However, in conditions such as the complex group of disorders termed the idiopathic interstitial ...

    • Images in Clinical Medicine

      Figure 1.

      • September 1, 2011
      • Fernandes das Neves M. and Oliveira S.
      • N Engl J Med 2011; 365:842
      • Free Full Text

      A 75-year-old woman was evaluated for a history of inflammatory joint pain in both hands. Symptoms of gastroesophageal reflux were present. Examination revealed multiple palpable masses in the soft tissue overlying the extensor surfaces of the elbows, wrists, and hands.

    • Correspondence

      To the Editor: Idiopathic pulmonary fibrosis is a complex genetic disease; mutations in surfactant protein C, telomerase, and surfactant protein A2 have been identified in familial cases of pulmonary fibrosis. We confirm a recent association with rs35705950 in the putative promoter of MUC5B and…

      • April 21, 2011
      • N Engl J Med 2011; 364:1576-1577
      • Free Full Text

      In this study, a single-nucleotide polymorphism in the mucus-forming gene MUC5B was strongly associated with the presence of idiopathic pulmonary fibrosis (IPF). These results replicate the findings of other investigators, also published in this issue.

    • Editorial

      Pulmonary fibrosis comprises a spectrum of disease phenotypes, including familial and idiopathic forms. Current research suggests that pulmonary fibrosis is a "two-hit" disease: a genetic predisposition to abnormal alveolar epithelial-cell regulation of the cell cycle and apoptosis combined with…

      • April 21, 2011
      • Boucher R.C.
      • N Engl J Med 2011; 364:1560-1561

        Pulmonary fibrosis comprises a spectrum of disease phenotypes, including familial and idiopathic forms. Current research suggests that pulmonary fibrosis is a “two-hit” disease: a genetic predisposition to abnormal alveolar epithelial-cell regulation of ...

      • Original Article

        The evidence that there is a genetic basis for idiopathic interstitial pneumonia is substantial, with familial aggregation confirmed through studies in twins, siblings raised apart, and multigenerational families. Interstitial lung disease has been associated with several pleiotropic genetic…

        • April 21, 2011
        • Seibold M.A., Wise A.L., Speer M.C., et al.
        • N Engl J Med 2011; 364:1503-1512
        • Free Full Text

        The pathobiology of idiopathic pulmonary fibrosis remains largely unknown. In this study, a variety of genetic techniques were used to implicate variants in the mucin-forming gene MUC5B as pivotal in a substantial proportion of patients with the disorder.

      • Editorial

        Therapies for cystic fibrosis have been limited to alleviating clinical manifestations, and although the duration and quality of patients' lives have improved, cystic fibrosis continues to inflict major burdens and shorten lives. In this issue of the Journal, Accurso and colleagues have taken a…

        • November 18, 2010
        • Welsh M.J.
        • N Engl J Med 2010; 363:2056-2057

          Therapies for cystic fibrosis have been limited to alleviating clinical manifestations, and although the duration and quality of patients' lives have improved, cystic fibrosis continues to inflict major burdens and shorten lives.1 In this issue of the ...

        • Original Article

          Cystic fibrosis is a progressive lung disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, an epithelial ion channel involved in salt and fluid transport in multiple organs, including the lung. Current treatments for cystic…

          • November 18, 2010
          • Accurso F.J., Rowe S.M., Clancy J.P., et al.
          • N Engl J Med 2010; 363:1991-2003
          • Free Full Text
          • CME

          In vitro studies have indicated that a molecule, VX-770, potentiates the activity of a mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. This trial involving persons with a copy of the mutant allele showed improvement in those who received the drug.

        • Original Article

          Idiopathic pulmonary fibrosis is a chronic, progressive lung disease of unknown cause that is characterized by the histopathologic pattern of usual interstitial pneumonia. Progression to end-stage respiratory insufficiency and death within 5 years after the onset of symptoms is characteristic. To…

          • August 12, 2010
          • The Idiopathic Pulmonary Fibrosis Clinical Research Network
          • N Engl J Med 2010; 363:620-628
          • Free Full Text

          In patients with advanced idiopathic pulmonary fibrosis, treatment with sildenafil was compared with placebo. In the sildenafil group, there was a nonsignificant trend toward improvement and some benefit in other physiological measures and symptom scores.

        • Case Records of the Massachusetts General Hospital

          Presentation of Case. Dr. Karen M. Winkfield (Radiation Oncology): A 56-year-old woman with a history of childhood Hodgkin's lymphoma was admitted to the emergency department of this hospital because of the sudden onset of dyspnea and hypotension. The patient had been in her usual state of health…

          • August 12, 2010
          • Ng A.K., Abramson J.S., Digumarthy S.R., Reingold J.S., Stone J.R.
          • N Engl J Med 2010; 363:664-675
          • CME

          A 56-year-old woman was admitted because of the sudden onset of dyspnea and hypotension. At 16 years of age, she had received combination chemotherapy and extended-field radiation therapy for Hodgkin's lymphoma. On admission, an electrocardiogram showed an acute myocardial infarction. A stent was placed, but hypotension and acidosis persisted, and the patient died.

        • Case Records of the Massachusetts General Hospital

          Presentation of Case. An 89-year-old man was admitted to the hospital because of progressive dyspnea. The patient had been in his usual state of health, with diabetes mellitus, coronary artery disease, and complete heart block, until 6 months before admission, when shortness of breath developed.…

          • April 22, 2010
          • Kradin R.L., Digumarthy S.R., Baggish A.L., Mark E.J.
          • N Engl J Med 2010; 362:1522-1531
          • Video

          An 89-year-old man was admitted to the hospital because of progressive dyspnea for 6 months, worsening over the past 3 days. He had a history of exposure to asbestos and had smoked cigarettes for many years. Imaging studies revealed a pleural plaque and pulmonary interstitial fibrosis with superimposed ground-glass opacities. Hypoxemia and intermittent hypotension occurred. Despite oxygen supplementation, mechanical ventilation, and pressor administration, a cardiac arrest occurred, and the patient died on the eighth hospital day. An autopsy was performed.

        • Review Article

          Elizabeth Blackburn, Jack Szostak, and Carol Greider were recently awarded the Nobel Prize in Physiology or Medicine for their elucidation of the structure and maintenance of telomeres (the tips of chromosomes). These investigators discovered that telomeres are DNA sequences with a structure that…

          • December 10, 2009
          • Calado R.T. and Young N.S.
          • N Engl J Med 2009; 361:2353-2365

            The Nobel Prize in Physiology or Medicine 2009 was recently awarded to three scientists for their work on telomeres, which are repetitive DNA structures at the tips of chromosomes, and the enzyme telomerase. Telomeres protect the genome from loss of genetic material. This review recounts the medical implications of telomeres and focuses on a group of diseases in which the loss of telomeres appears to be causal.

          • Case Records of the Massachusetts General Hospital

            Presentation of Case. A 27-year-old man was seen in the outpatient pulmonary division of this hospital because of progressive dyspnea and decreased exercise tolerance. Approximately 2 years earlier, the patient noted a slight decrease in his exercise tolerance. He was able to exercise regularly and…

            • October 15, 2009
            • Tager A.M., Sharma A., Mark E.J.
            • N Engl J Med 2009; 361:1585-1593

              A 27-year-old man was seen at this hospital because of progressive dyspnea and decreased exercise tolerance during the past 2 years. Imaging studies showed diffuse pulmonary fibrosis. The patient had lighter skin than many in his family, although he reported that several family members had light skin and respiratory problems. He had a history of easy bruising. On examination, his skin was pale, and there was clubbing of the fingers and toes, normal breath sounds, pigmented irises, and horizontal nystagmus. A diagnostic procedure was performed.

            • Case Records of the Massachusetts General Hospital

              Presentation of Case. Dr. Sang-Woo (Steve) Han (Neurology): A 37-year-old woman was seen in the emergency department of this hospital because of a seizure. Four months earlier, episodes of vertigo began to occur several times a week that lasted up to several hours and were associated with nausea…

              • February 19, 2009
              • Cros D., Gonzalez R.G., Mark E.J.
              • N Engl J Med 2009; 360:802-809

                A 37-year-old woman had a 4-month history of episodes of vertigo, followed by tinnitus, decreased hearing in her right ear, and right facial weakness; on the day of admission, she had a generalized seizure. On admission, she was confused and combative and had garbled speech, a right facial droop, and generalized hyperreflexia. Magnetic resonance imaging of the brain and spinal cord revealed multifocal linear and nodular enhancement of the leptomeninges. A diagnostic procedure was performed.

              • Case Records of the Massachusetts General Hospital

                Presentation of Case. Dr. Nancy Cibotti-Granof (Medicine): A 46-year-old woman with end-stage renal disease was seen by a rheumatology consultant because of stiffness of her joints and skin. The patient had been well except for mild asthma until 7 years earlier, when group A streptococcal pneumonia…

                • February 21, 2008
                • Kay J., Bazari H., Avery L.L., Koreishi A.F.
                • N Engl J Med 2008; 358:827-838

                  A 46-year-old woman was seen by a rheumatology consultant because of stiffness of the joints and skin. She had been well until 7 years earlier, when an episode of group A streptococcal pneumonia complicated by septic shock left her with chronic kidney disease and a painful peripheral neuropathy. Three years later, gradually progressive stiffness of the skin of her hands and feet developed, with pain and stiffness of the joints; renal failure worsened, and respiratory distress and congestive heart failure developed. A diagnostic procedure was performed.

                • Clinical Implications of Basic Research

                  "Death occurred about three months and a half after the onset of the acute disease and the lung was two thirds of the normal size, grayish in color, and hard as cartilage. Microscopically these areas showed advanced fibrotic changes and great thickening of the alveolar walls." Thus did Sir William…

                  • March 29, 2007
                  • Verma S. and Slutsky A.S.
                  • N Engl J Med 2007; 356:1370-1372

                    The signaling molecule caveolin-1 provides protection against pulmonary fibrosis in a mouse model and counters the profibrotic effects of transforming growth factor β1 (TGF-β1)..

                  • Original Article

                    Idiopathic pulmonary fibrosis has a predictable, progressive clinical course that ultimately leads to respiratory failure. Irreversible fibrosis is the hallmark of the disease, which has a characteristic radiographic appearance most often associated with the pathological lesion of usual…

                    • March 29, 2007
                    • Armanios M.Y., Chen J.J.-L., Cogan J.D., et al.
                    • N Engl J Med 2007; 356:1317-1326
                    • Free Full Text

                    Mutations affecting both components of the telomerase enzyme, hTERT and hTR, are associated with familial idiopathic pulmonary fibrosis, and carriers of such mutations have shorter telomeres than do noncarrier family members. This finding suggests that the disease may be triggered by a loss of alveolar cells, the progenitors of which may be limited by short telomeres.

                  • Original Article

                    Idiopathic pulmonary fibrosis is a chronic progressive interstitial pneumonia with a poor prognosis.– It has been proposed that a pathogenetic mechanism of idiopathic pulmonary fibrosis is repeated lung injury, with aberrant progressive fibrotic reaction.– If this is the case, it may explain…

                    • November 24, 2005
                    • Demedts M., Behr J., Buhl R., et al.
                    • N Engl J Med 2005; 353:2229-2242
                    • Free Full Text

                    Idiopathic pulmonary fibrosis is a progressive disorder characterized by loss of lung function; there is no effective treatment. In this multinational, randomized, placebo-controlled trial with all patients receiving azathioprine and prednisone, acetylcysteine was shown to slow the rate of deterioration of lung function. There was no effect on survival.

                  Page

                  Medical Meetings Pediatrics Conferences and Meetings

                  2012 Certifying Examinations of the American Board of Pediatrics

                  The general pediatrics examination will be held in various cities, Oct. 16-18. Registration for first-time applicants is ongoing through May 3. Registration for re-registrants is ongoing through May 24. The following subspecialty examinations will be held in various cities: "Hospice and Palliative Medicine" (Oct. 4); "Pediatric Transplant Hepatology" (Oct. 11); "Pediatric Cardiology" (Nov. 7); "Pediatric Pulmonology" (Nov. 8); "Medical Toxicology" (Nov. 12); and "Pediatric Critical Care Medicine" (Nov. 14). Registration for first-time applicants is ongoing through April 30. Registration for re-registrants is ongoing through June 15.

                  Contact the American Board of Pediatrics, 111 Silver Cedar Court, Chapel Hill, NC 27514-1513; or call (919) 929-0461; or fax (919) 918-7114 or (919) 929-9255; or see http://www.abp.org .

                  More Medical Meetings